1
|
Daniels C, Aluso A, Burke-Shyne N, Koram K, Rajagopalan S, Robinson I, Shelly S, Shirley-Beavan S, Tandon T. Decolonizing drug policy. Harm Reduct J 2021; 18:120. [PMID: 34838050 PMCID: PMC8626718 DOI: 10.1186/s12954-021-00564-7] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Accepted: 10/31/2021] [Indexed: 11/10/2022] Open
Abstract
This paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries. It demonstrates the racist and xenophobic impact of drug control policy and proposes a path to move beyond oppressive systems and structures. The 'colonization of drug control' refers to the use of drug control by states in Europe and America to advance and sustain the systematic exploitation of people, land and resources and the racialized hierarchies, which were established under colonial control and continue to dominate today. Globally, Black, Brown and Indigenous peoples are disproportionately targeted for drug law enforcement and face discrimination across the criminal system. These communities face higher arrest, prosecution and incarceration rates for drug offenses than other communities, such as majority populations, despite similar rates of drug use and selling among (and between) different races. Current drug policies have contributed to an increase in drug-related deaths, overdoses and sustained transnational criminal enterprises at the expense of the lives of people who use drugs, their families and greater society. This review provides further evidence of the need to reform the current system. It outlines a three-pillared approach to rebuilding drug policy in a way that supports health, dignity and human rights, consisting of: (1) the decriminalization of drugs and their use; (2) an end to the mass incarceration of people who use drugs; (3) the redirection of funding away from ineffective and punitive drug control and toward health and social programs.
Collapse
Affiliation(s)
- Colleen Daniels
- Harm Reduction International (HRI), 61 Mansell Street, Aldgate, London, E1 8AN, UK.
| | - Aggrey Aluso
- Open Society Foundation, Open Society Initiative for Eastern Africa, ACS Plaza, 1st Floor, Lenana Road, P O Box 2193-00202, Nairobi, 00202, Kenya
| | - Naomi Burke-Shyne
- Harm Reduction International (HRI), 61 Mansell Street, Aldgate, London, E1 8AN, UK
| | - Kojo Koram
- Birkbeck College, University of London, Malet St, London, WC1E 7HX, UK
| | - Suchitra Rajagopalan
- Harm Reduction International (HRI), 61 Mansell Street, Aldgate, London, E1 8AN, UK
| | | | - Shaun Shelly
- TB/HIV Care, South African Network of People Who Use Drugs (SANPUD), University of Pretoria, Department of Family Medicine, 7th Floor, 11 Adderley Street, Cape Town City Centre, Cape Town, 8001, South Africa
| | - Sam Shirley-Beavan
- Harm Reduction International (HRI), 61 Mansell Street, Aldgate, London, E1 8AN, UK
| | - Tripti Tandon
- Lawyers Collective, 4th floor, Jalaram Jyot, 63 Janmabhoomi Marg, Fort, Mumbai, 400001, India
| |
Collapse
|
2
|
Akuffo R, Armah G, Clemens M, Kronmann KC, Jones AH, Agbenohevi P, Sagoe K, Puplampu N, Talla Nzussouo N, Ampofo W, Koram K, Duplessis C, Dueger E. Prevalence of enteric infections among hospitalized patients in two referral hospitals in Ghana. BMC Res Notes 2017; 10:292. [PMID: 28716138 PMCID: PMC5514524 DOI: 10.1186/s13104-017-2621-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 07/12/2017] [Indexed: 01/30/2023] Open
Abstract
Background Diarrhea is an important cause of morbidity and mortality worldwide. In Africa and Ghana in particular, it is estimated to contribute directly to 19 and 25% of pediatric mortality among children under 5 years, respectively. Methods Surveillance for hospitalized acute diarrheal illness was initiated in November 2010 through October 2012 in a referral hospital in southern Ghana, and a teaching hospital in northern Ghana. Consenting hospitalized patients who met a standardized case definition for acute diarrheal illness provided demographic and epidemiologic data. Stool samples were collected and tested by culture for bacteria and by enzyme immunoassays for a panel of viruses and parasites. Results A total of 429 patients were enrolled; 216 (50.3%) were under 5 years, and 221 (51.5%) were females. Stool samples were received from 153 patients. Culture isolates included Shigella sp., Salmonella spp., Plesiomonas sp. and Vibrio cholerae. Of 147 samples tested for viruses, 41 (27.9%) were positive for rotaviruses, 11 (7.5%) for astroviruses, 10 (6.8%) for noroviruses, and 8 (5.4%) for adenoviruses. Of 116 samples tested for parasitic infections; 4 (3.4%) were positive for Cryptosporidium sp. and 3 (2.6%) for Giardia lamblia. Of the enrolled patients, 78.8% had taken antibiotics prior to sample collection. Conclusions Diarrheal pathogens were identified across all ages, however, predominantly (81%) in the children under 5 years of age. This study also detected high antibiotic use which has the potential of increasing antibiotic resistance. The most common enteric pathogen detected (49.4%) was rotavirus. Electronic supplementary material The online version of this article (doi:10.1186/s13104-017-2621-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- R Akuffo
- Noguchi Memorial Institute for Medical Research, Accra, Ghana. .,Global Disease Detection & Response Program (GDDRP), U.S. Naval Medical Research Unit No. 3 (NAMRU-3), Cairo, Egypt. .,Global Disease Detection (GDD) Egypt Regional Center, U.S. Naval Medical Research Unit No. 3, NAMRU-3, PSC 452, P.O Box 5000, Foster city, FPO, AE 09835-9998, USA.
| | - G Armah
- Noguchi Memorial Institute for Medical Research, Accra, Ghana
| | - M Clemens
- Global Disease Detection & Response Program (GDDRP), U.S. Naval Medical Research Unit No. 3 (NAMRU-3), Cairo, Egypt.,Global Disease Detection (GDD) Egypt Regional Center, U.S. Naval Medical Research Unit No. 3, NAMRU-3, PSC 452, P.O Box 5000, Foster city, FPO, AE 09835-9998, USA
| | - K C Kronmann
- U.S. Naval Medical Research Unit No. 3, Ghana Detachment, Accra, Ghana.,Uniformed Services University of the Health Sciences, Bethesda, MD, USA
| | - A H Jones
- Global Disease Detection & Response Program (GDDRP), U.S. Naval Medical Research Unit No. 3 (NAMRU-3), Cairo, Egypt.,Global Disease Detection (GDD) Egypt Regional Center, U.S. Naval Medical Research Unit No. 3, NAMRU-3, PSC 452, P.O Box 5000, Foster city, FPO, AE 09835-9998, USA
| | | | - K Sagoe
- Tamale Teaching Hospital, Tamale, Ghana
| | - N Puplampu
- U.S. Naval Medical Research Unit No. 3, Ghana Detachment, Accra, Ghana
| | - N Talla Nzussouo
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - W Ampofo
- Noguchi Memorial Institute for Medical Research, Accra, Ghana
| | - K Koram
- Noguchi Memorial Institute for Medical Research, Accra, Ghana
| | - C Duplessis
- U.S. Naval Medical Research Unit No. 3, Ghana Detachment, Accra, Ghana
| | - E Dueger
- Global Disease Detection & Response Program (GDDRP), U.S. Naval Medical Research Unit No. 3 (NAMRU-3), Cairo, Egypt.,Global Disease Detection (GDD) Egypt Regional Center, U.S. Naval Medical Research Unit No. 3, NAMRU-3, PSC 452, P.O Box 5000, Foster city, FPO, AE 09835-9998, USA.,U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
3
|
Otchere ID, Asante-Poku A, Osei-Wusu S, Baddoo A, Sarpong E, Ganiyu AH, Aboagye SY, Forson A, Bonsu F, Yahayah AI, Koram K, Gagneux S, Yeboah-Manu D. Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana. Tuberculosis (Edinb) 2016; 99:147-154. [PMID: 27450017 PMCID: PMC4978697 DOI: 10.1016/j.tube.2016.05.014] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Revised: 05/26/2016] [Accepted: 05/28/2016] [Indexed: 11/29/2022]
Abstract
We spoligotyped and screened 1490 clinical Mycobacterium tuberculosis complex strains from Northern and Greater Accra regions of Ghana against INH and RIF using the microplate alamar blue phenotypic assay. Specific drug resistance associated genetic elements of drug resistant strains were analyzed for mutations. A total of 111 (7.5%), 10 (0.7%) and 40 (2.6%) were mono-resistant to INH, RIF, and MDR, respectively. We found the Ghana spoligotype to be associated with drug resistance (INH: 22.1%; p = 0.0000, RIF: 6.2%; p = 0.0103, MDR: 4.6%; p = 0.0240) as compared to the Cameroon spoligotype (INH: 6.7%, RIF: 2.4%, MDR: 1.6%). The propensity for an isolate to harbour katG S315T mutation was higher in M. tuberculosis (75.8%) than Mycobacterium africanum (51.7%) (p = 0.0000) whereas the opposite was true for inhApro mutations; MAF (48.3%) compared to MTBSS (26.7%) (p = 0.0419). We identified possible novel compensatory INH resistance mutations in inhA (G204D) and ahpCpro (-88G/A and -142G/A) and a novel ndh mutation K32R. We detected two possible rpoC mutations (G332R and V483G), which occurred independently with rpoB S450L, respectively. The study provides the first evidence that associate the Ghana spoligotype with DR-TB and calls for further genome analyses for proper classification of this spoligotype and to explore for fitness implications and mechanisms underlying this observation.
Collapse
Affiliation(s)
- I D Otchere
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana; Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana
| | - A Asante-Poku
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - S Osei-Wusu
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - A Baddoo
- Chest Clinic, Korle-BU Teaching Hospital, Accra, Ghana
| | - E Sarpong
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - A H Ganiyu
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - S Y Aboagye
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - A Forson
- Chest Clinic, Korle-BU Teaching Hospital, Accra, Ghana
| | - F Bonsu
- Ghana Health Service, Ministry of Health, Accra, Ghana
| | - A I Yahayah
- Chest Department, Tamale Teaching Hospital, Tamale, Ghana
| | - K Koram
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
| | - S Gagneux
- Swiss TPH, Basel, Switzerland; University of Basel, Basel, Switzerland
| | - D Yeboah-Manu
- Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
| |
Collapse
|
4
|
Oduro A, Anyorigiya T, Anto F, Amenga-Etego L, Ansah N, Atobrah P, Ansah P, Koram K, Hodgson A. A randomized, comparative study of supervised and unsupervised artesunate–amodiaquine, for the treatment of uncomplicated malaria in Ghana. Annals of Tropical Medicine & Parasitology 2013; 102:565-76. [DOI: 10.1179/136485908x337508] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
5
|
Egyir B, Brown C, Wilson M, Koram K. Distribution and Genetic Diversity of Plasmodium falciparum Erythrocyte Binding Antigen 175 and Clinical Outcome of Malaria in the Kassena-Nankana District. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
6
|
Abstract
We evaluated prospectively, compliance with the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines on termination of pregnancy (TOP) in a cohort of 340 women referred for termination of pregnancy in 2003 at South Tyneside Foundation Trust. The number of referrals represented one-fifth of all births in our unit during the study period. Teenagers were the largest single group of women requesting termination of pregnancy and the majority were nulliparous. There were 85 women who were seeking a repeat termination of pregnancy. The RCOG minimum referral standard was met in 80% of cases. A good number of women were unsure of their menstrual dates and only 5% had used emergency contraception. A total of 96% were either not using contraception, using condoms or taking oral contraceptives irregularly. A total of 50% of the women attended hospital without a Certificate A being completed by the referring practitioner. Surgical termination was preferred over medical termination in the cohort of women who could exercise a choice. It is possible to comply with the RCOG Termination of Pregnancy guidelines to a large extent in a District General Hospital, with some innovation. Close liaison between General Practitioners, Family Planning Clinics and Acute Hospitals is required. The adoption of agreed referral requirements and pathways would help in the delivery of a high quality service as advocated by the guideline.
Collapse
Affiliation(s)
- U Esen
- Department of Obstetrics and Gynaecology, South Tyneside NHS Foundation Trust, Harton Lane, South Shields, UK.
| | | | | | | | | |
Collapse
|
7
|
Quashie NB, Ofori-Adjei D, Duah NO, Koram K. <i>In vitro</i> susceptibility of <i>Plasmodium falciparum</i> isolates to chloroquine and other antimalarial drugs in Ghana. Ghana Med J 2006. [DOI: 10.4314/gmj.v38i4.36009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
8
|
Arnot DE, Koram K, Kilama W. Malaria vaccine research and testing in Africa. ACTA ACUST UNITED AC 2006; 14:254-6. [PMID: 17040776 DOI: 10.1016/s0169-4758(98)01240-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- D E Arnot
- Institute of Cell, Animal and Population Biology, Edinburgh University, Ashworth Laboratories, King's Buildings, West Mains Road, Edinburgh, UK EH9 3JT
| | | | | |
Collapse
|
9
|
Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JAL, Theander TG, Akanmori BD, Polley S, Conway DJ, Koram K, McBride JS. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun 2004; 72:6492-502. [PMID: 15501780 PMCID: PMC522997 DOI: 10.1128/iai.72.11.6492-6502.2004] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
This longitudinal prospective study shows that antibodies to the N-terminal block 2 region of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) are associated with protection against clinical malaria in an area of stable but seasonal malaria transmission of Ghana. Antibodies to the block 2 region of MSP-1 were measured in a cohort of 280 children before the beginning of the major malaria transmission season. The cohort was then actively monitored for malaria, clinically and parasitologically, over a period of 17 months. Evidence is presented for an association between antibody responses to block 2 and a significantly reduced risk of subsequent clinical malaria. Furthermore, statistical survival analysis provides new information on the duration of the effect over time. The results support a conclusion that the block 2 region of MSP-1 is a target of protective immunity against P. falciparum and, thus, a promising new candidate for the development of a malaria vaccine.
Collapse
Affiliation(s)
- David R Cavanagh
- Institute of Cell, Animal and Population Biology, School of Biological Sciences, University of Edinburgh, King's Buildings, West Mains Rd., EH9 3JT, Scotland, UK.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Dodoo D, Staalsoe T, Giha H, Kurtzhals JA, Akanmori BD, Koram K, Dunyo S, Nkrumah FK, Hviid L, Theander TG. Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children. Infect Immun 2001; 69:3713-8. [PMID: 11349035 PMCID: PMC98376 DOI: 10.1128/iai.69.6.3713-3718.2001] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a variant antigen expressed on the surface of infected erythrocytes. Each parasite genome contains about 40 PfEMP1 genes, but only 1 PfEMP1 gene is expressed at a given time. PfEMP1 serves as a parasite-sequestering ligand to endothelial cells and enables the parasites to avoid splenic passage. PfEMP1 antibodies may protect from disease by inhibiting sequestration, thus facilitating the destruction of infected erythrocytes in the spleen. In this study, we have measured antibodies in Ghanaian children to a conserved region of PfEMP1 by enzyme-linked immunosorbent assay and antibodies to variant molecules on erythrocytes infected with field isolates of P. falciparum by flow cytometry. Based on close clinical monitoring, the children were grouped into those who did (susceptible) and those who did not (protected) have malaria during the season. The prevalences of antibodies to both the conserved PfEMP1 peptide and the variant epitopes were greater than 50%, and the levels of immunoglobulin G (IgG) correlated with age. The levels of antibodies to both the conserved peptide and the variant epitopes were higher in protected than in susceptible children. After correcting for the effect of age, the levels of IgG to variant antigens on a Sudanese and a Ghanaian parasite isolate remained significantly higher in protected than in susceptible children. Thus, the levels of IgG to variant antigens expressed on the surface of infected erythrocytes correlated with protection from clinical malaria. In contrast, the levels of IgG to a peptide derived from a conserved part of PfEMP1 did not correlate with protection from malaria.
Collapse
Affiliation(s)
- D Dodoo
- Immunology and Epidemiology Units, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, Hviid L. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 2000; 165:3309-16. [PMID: 10975848 DOI: 10.4049/jimmunol.165.6.3309] [Citation(s) in RCA: 228] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
In areas of intense Plasmodium falciparum transmission, clinical immunity is acquired during childhood, and adults enjoy substantial protection against malaria. An exception to this rule is pregnant women, in whom malaria is both more prevalent and severe than in nonpregnant women. Pregnancy-associated malaria (PAM) in endemic areas is concentrated in the first few pregnancies, indicating that protective immunity to PAM is a function of parity. The placenta is often heavily infected in PAM, and placental parasites show a striking preference for chondroitin sulfate A (CSA) as an adhesion receptor. Plasma Abs from malaria-exposed multiparous women are able to interfere with binding of P. falciparum parasites to CSA in vitro, and acquisition of Abs interfering with CSA-specific parasite sequestration thus appears to be a critical element in acquired protection against PAM. Here we show that adults from an area of hyperendemic P. falciparum transmission generally possessed low levels of Abs specifically recognizing surface Ags expressed by a CSA-adhering parasite isolate, while unselected isolates were well recognized. In marked contrast, most third-trimester pregnant women from that area had very high plasma levels of such Abs. Plasma levels of Abs specifically recognizing the CSA-adhering isolate strongly depended on parity, whereas recognition of CSA-nonadhering isolates did not. Finally, we demonstrate a clear correlation between plasma levels of Abs recognizing the CSA-specific isolate and the ability to interfere with its sequestration to CSA in vitro. Our study supports the hypothesis that Abs inhibiting CSA-specific parasite sequestration are important in acquisition of protection against PAM.
Collapse
MESH Headings
- Adult
- Animals
- Antibodies, Protozoan/blood
- Antibodies, Protozoan/pharmacology
- Antigen-Antibody Reactions
- Antigens, Protozoan/immunology
- Antiprotozoal Agents/blood
- Antiprotozoal Agents/pharmacology
- Cell Adhesion/immunology
- Child
- Chondroitin Sulfates/immunology
- Erythrocyte Membrane/immunology
- Erythrocyte Membrane/parasitology
- Female
- Humans
- Immunophenotyping
- Immunosuppressive Agents/blood
- Immunosuppressive Agents/pharmacology
- Malaria, Falciparum/blood
- Malaria, Falciparum/epidemiology
- Malaria, Falciparum/immunology
- Malaria, Falciparum/parasitology
- Male
- Parity/immunology
- Plasmodium falciparum/growth & development
- Plasmodium falciparum/immunology
- Pregnancy
- Pregnancy Complications, Parasitic/blood
- Pregnancy Complications, Parasitic/epidemiology
- Pregnancy Complications, Parasitic/immunology
- Pregnancy Complications, Parasitic/parasitology
- Pregnancy Trimester, Third/immunology
Collapse
Affiliation(s)
- C H Ricke
- Centre for Medical Parasitology at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet) and Institute for Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark
| | | | | | | | | | | | | |
Collapse
|
12
|
Dodoo D, Theander TG, Kurtzhals JA, Koram K, Riley E, Akanmori BD, Nkrumah FK, Hviid L. Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infect Immun 1999; 67:2131-7. [PMID: 10225865 PMCID: PMC115948 DOI: 10.1128/iai.67.5.2131-2137.1999] [Citation(s) in RCA: 93] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The 19-kDa conserved C-terminal part of the Plasmodium falciparum merozoite surface protein 1 (PfMSP119) is a malaria vaccine candidate antigen, and human antibody responses to PfMSP119 have been associated with protection against clinical malaria. In this longitudinal study carried out in an area of stable but seasonal malaria transmission with an estimated parasite inoculation of about 20 infective bites/year, we monitored 266 3- to 15-year-old Ghanaian children clinically and parasitologically over a period of 18 months. Blood samples were collected at the beginning of the study before the major malaria season in April and after the season in November. Using enzyme-linked immunosorbent assay, we measured antibody responses to recombinant gluthathione S-transferase-PfMSP119 fusion proteins corresponding to the Wellcome and MAD20 allelic variants in these samples. Prevalence of antibodies recognizing the Wellcome 19 construct containing both epidermal growth factor (EGF)-like motifs in Wellcome type PfMSP119 was about 30%. Prevalence of antibodies to constructs containing only the first EGF domain from either Wellcome or MAD20 type PfMSP119 was about 15%, whereas antibodies recognizing a construct containing only the second EGF domain of MAD20 type PfMSP119 was found in only about 4% of the donors. Neither the prevalence nor the levels of any of the antibody specificities varied significantly with season, age, or sex. Significantly, and in contrast to previous reports from other parts of West Africa, we found no evidence of an association between antibody responses to PfMSP119 and clinical protection against malaria.
Collapse
Affiliation(s)
- D Dodoo
- Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
| | | | | | | | | | | | | | | |
Collapse
|
13
|
McGuinness D, Koram K, Bennett S, Wagner G, Nkrumah F, Riley E. Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans R Soc Trop Med Hyg 1998; 92:527-31. [PMID: 9861370 DOI: 10.1016/s0035-9203(98)90902-6] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
In areas endemic for Plasmodium falciparum, clinical malaria is believed to be less common in infants than in older children, but specific case definitions have rarely been determined for this age group. As malaria case definitions are known to be both age- and site-specific, assessment of the risk of disease in infancy requires the development of appropriate diagnostic criteria. In southern Ghana, 154 children were recruited at birth and monitored for fever and malaria infection until 2 years of age. Logistic regression was used to model fever risk as a continuous function of parasite density to determine case definitions for the diagnosis of clinical malaria, and to determine age- and season-specific estimates of the fraction of fevers attributable to malaria (AF); 2360 observations were made on 154 children. For fevers defined by a measured temperature > or = 37.5 degrees C, the estimated population AF was 44% (95% confidence interval 34-53). Estimates of AF varied with age and season. For infants, AF was 51% during the wet season and 22% during the dry season; for children over one year of age, AF was 89% during the wet season and 36% during the dry season. The estimated parasite density threshold for initiation of a febrile episode was 100 parasites per microL of blood in infants, compared with 3500 parasites per microL for children over one year of age. Using these case definitions, the incidence of clinical malaria was estimated at 0.09 cases per child-year at risk for children less than 6 months of age, 0.40 for children aged 6-11 months, and 0.69 for children aged 12-23 months. Of 66 cases of clinical malaria, only 3 were observed in children under 5 months of age. We concluded that, although most fevers in infants are not due to malaria, infant clinical malaria may occur at extremely low parasite densities. This may be indicative of a lack of anti-disease immunity in this age group. In southern Ghana, an infant with axillary temperature > or = 37.5 degrees C and parasitaemia > or = 100/microL should be considered to have clinical malaria. Nevertheless, the incidence of clinical malaria is very low in children under 6 months of age, confirming that they are significantly protected from clinical malaria compared to older children.
Collapse
Affiliation(s)
- D McGuinness
- Institute of Cell, Animal and Population Biology, University of Edinburgh, UK
| | | | | | | | | | | |
Collapse
|
14
|
Riley E, Koram K, McGuinness D, Wagner G, Bennett S, Nkrumah F. Immunity to malaria in African infants. Parasitol Int 1998. [DOI: 10.1016/s1383-5769(98)80131-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
15
|
Wagner G, Koram K, McGuinness D, Bennett S, Nkrumah F, Riley E. High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. Am J Trop Med Hyg 1998; 59:115-23. [PMID: 9684638 DOI: 10.4269/ajtmh.1998.59.115] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The incidence of Plasmodium falciparum infection has been followed in a birth cohort of 71 infants in southern Ghana, an area of perennial malaria transmission. Parasite DNA detection established the presence of a high rate of infection in newborns (13.6%), a low level of infection from two to 26 weeks (1.5-9.7%) and a steadily increasing parasite rate from 26 weeks of age. The median age to first infection was 42 weeks. Five cases of fever (temperature > or = 37.5 degrees C) and parasite density greater than 1,000 parasites/microl of blood, all in children more than 18 weeks of age, were considered possible cases of clinical malaria. The risk of infection was almost three times higher in the wet season than in the dry season and increased significantly from the age of 18 weeks. The level of malaria-specific IgG at birth was positively correlated with risk of infection in children 6-12 months of age, indicating that maternally derived anti-malarial IgG is correlated with exposure to malaria infection. There was no association between malaria-specific IgG at birth and risk of infection in children 0-6 months of age. However, infants do appear to possess mechanisms to limit parasite growth and a role for maternal antibody cannot be ruled out.
Collapse
MESH Headings
- Adult
- Age Factors
- Animals
- Antibodies, Protozoan/blood
- Cohort Studies
- DNA, Protozoan/blood
- Female
- Ghana/epidemiology
- Humans
- Immunity, Maternally-Acquired
- Immunoglobulin G/blood
- Incidence
- Infant
- Infant, Newborn
- Longitudinal Studies
- Malaria, Falciparum/diagnosis
- Malaria, Falciparum/epidemiology
- Malaria, Falciparum/immunology
- Male
- Plasmodium falciparum/genetics
- Plasmodium falciparum/immunology
- Plasmodium falciparum/isolation & purification
- Polymerase Chain Reaction
- Pregnancy
- Pregnancy Complications, Parasitic/diagnosis
- Pregnancy Complications, Parasitic/epidemiology
- Pregnancy Complications, Parasitic/immunology
- Prevalence
- Prospective Studies
- Risk Factors
- Seasons
Collapse
Affiliation(s)
- G Wagner
- Institute of Cell, Animal and Population Biology, University of Edinburgh, United Kingdom
| | | | | | | | | | | |
Collapse
|